Bora CDMO Bora CDMO

X

Digital content for Shorla Oncology

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Shorla Oncology
Ireland Flag
Country
Country
Ireland
Address
Address
Questum Acceleration Center Ballingarrane Science & Technology Park Clonmel, Co. Tipperary E91 V329
Telephone
Telephone
+353 (052) 618 4362

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.businesswire.com/news/home/20240408742912/en

BUSINESSWIRE
08 Apr 2024

https://www.businesswire.com/news/home/20240109305168/en

BUSINESSWIRE
09 Jan 2024

https://www.prnewswire.com/news-releases/shorla-oncology--eversana-announce-us-commercial-launch-of-fda-approved-jylamvo-the-first-and-only-oral-methotrexate-solution-approved-in-the-us-for-adults-302018960.html

PR NEWSWIRE
19 Dec 2023

https://www.businesswire.com/news/home/20231207999977/en

BUSINESSWIRE
07 Dec 2023

https://www.businesswire.com/news/home/20231031719564/en

BUSINESSWIRE
31 Oct 2023

https://www.businesswire.com/news/home/20231004152524/en

BUSINESSWIRE
04 Oct 2023

https://www.businesswire.com/news/home/20230706685508/en

BUSINESSWIRE
06 Jul 2023

https://www.prnewswire.com/news-releases/shorla-oncology--eversana-announce-commercial-launch-of-recent-fda-approved-nelarabine-injection-for-the-treatment-of-t-cell-leukemia-across-the-united-states-301825409.html

PR NEWSWIRE
16 May 2023

https://www.prnewswire.com/news-releases/shorla-pharma-announces-partnership-with-eversana-to-support-the-launch-and-commercialization-of-t-cell-leukemia-treatment-301356204.html

PRNEWSWIRE
17 Aug 2021

https://www.businesswire.com/news/home/20210423005122/en/Shorla-Pharma-Announces-FDA-Filing-Acceptance-and-Priority-Review-for-T-cell-Leukemia-Treatment

BUSINESSWIRE
23 Apr 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY